国产在线一区二区三区AV,国产AV天堂无码一区二区三区,黄色电影免费观看,国内精品久久久久久99蜜桃

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

国产AV无码专区亚洲AV| 精品国产一区二区三区免费| 色偷偷色噜噜狠狠网站久久| 久久久久久无码大片A片| 色噜噜狠狠一区二区三区| 仙踪林果冻传媒一区二区| 成人奭片免费观看| 国产肉体XXXX裸体784大胆| 亚洲av成人无码久久www| 国产精品一区二区AV白丝在线| 国产精品videossex久久发布| 精品久久久久久中文字幕| 中文字幕一区二区人妻| 欧美视频毛片在线播放| 国产农村妇女毛片精品久久| 国产日产久久高清欧美一区| 100国产精品人妻无码| 国产肉体XXXX裸体784大胆| 久久精品国产成人| 国产成人一区二区三区免费视频| 中文有无人妻VS无码人妻激烈| 久久精品AⅤ无码中文字字幕| 国产乱人伦偷精品视频a人人澡| 赵东苏菲花都兵王免费阅读| 伊人久久综合精品无码AV专区 | 阳茎伸入女人阳道视频免费| 凹凸久久人人澡超碰凹凸| 亚洲午夜久久久久妓女影院| 性色AV浪潮AV色欲AV一区| 欧美深度肠交惨叫| 亚洲国产一区二区A毛片日本| 99久久伊人精品综合观看| 欧美18VIDEOSEX极品| 久久久久AV综合网成人| 蜜臀av夜夜澡人人爽人人| 国产国产人免费人成免费视频| 精品无码国产一区二区三区麻豆 | babesvideos性欧美| 国产一区二区三区久久精品| 亚洲一区二区三区写真| 国产精品久久久久精品|